US veterans with chronic cardiovascular conditions experiencing homelessness and unstable housing have lower outpatient care utilization.
Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes.
The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.